Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Amarillo Biosciences Inc

+ Add to Watchlist


0.2240 USD 0.0010 0.44%

As of 20:10:02 ET on 05/27/2015.

Company Profile for Amarillo Biosciences Inc (AMAR)

Amarillo Biosciences, Inc. develops biologics for the treatment of human and animal diseases. The Company develops oral interferon alpha as a treatment for a variety of conditions, including Sjogren's syndrome, hepatitis B and C, and fibromyalgia syndrome.

Contact Information

Amarillo Biosciences Inc

4134 Business Park Drive
Amarillo, TX 79110-4225
United States
Phone: 1-806-376-1741
Fax: 1-806-376-9301

Key Executives for Amarillo Biosciences Inc (AMAR)

Stephen T Chen "Steve"Chairman/President/CEO/COOBernard CohenVP/CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil